The St.Gallen International Consensus on the primary treatment of individuals with early breast cancer

The St.Gallen International Breast Cancer Conference concludes with its prestigious St.Gallen International Breast Cancer Consensus Session. In this last session, a panel with over 60 breast cancer specialists from all over the world discusses developments from the past two years in the treatment of individuals with early breast cancer.

A skilled moderator guides panelists from all relevant fields through the session to provide evidence-based input. The panelists reach a consensus on challenging issues and define adapted diagnostic and therapeutic aspects. Consideration of cultural issues and economic influences is a major challenge.

PUBLICATION 2023 The anticipated 2023 edition of the St.Gallen International Consensus Guidelines is coming up soon. Stay tuned for its release in the prestigious Annals of Oncology and be at the forefront of cutting-edge care.

Following the conference, a group of gifted authors completes the current guidelines with the new findings and/or decisions and asks the panelists to comment on the publication. Only a few months later, the St.Gallen International Breast Cancer Consensus Guidelines are published in the esteemed Journal Annals of Oncology. The St.Gallen Guidelines are updated every second year with the most recent research findings, making them globally accessible to both breast cancer specialists and their patients. The St.Gallen Consensus is a testament to the commitment to excellence in the treatment of individuals with early breast cancer.